Cybin Announces Promising Results from Feasibility Study Measuring Psychedelic Effects on the Brain
Psychedelic therapy is gaining ground in the psychiatric and medical community. After what was essentially a ban on scientific study of hallucinogenic compounds for over three decades, new data are […]
How Does Ketamine Affect the Brain Over Time? Kernel Founder Tests his Invention
Kernel, a non-invasive neuroimaging company, and Cybin Inc. (NYSE American: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics,” have announced results from an innovative study involving ketamine and […]